BioSpace News Archive

Verrix, a developer of solutions for rapid and accurate sterilization confirmation, engaged with sterile processing professionals while exhibiting at the recent International Association of Healthcare Central Service Materiel Management 2019 Annual Conference & Expo.

SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its first quarter of 2019, ended March 31, 2019, after the market close on Wednesday, May 15, 2019.

Preventice Solutions announced today the presentation of data showing the critical impact the length of the monitoring period has when using ambulatory remote ECG monitoring to detect atrial fibrillation (AF).

AmerisourceBergen, a global healthcare solutions leader, released its Corporate Citizenship Report: 2018 Year in Review detailing how the company continues to advance sustainable practices and community investment to create healthier futures around the world.

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the first quarter ended March 31, 2019.

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Tarceva®1 tablets, 100 and 150 mg, in the U.S.

Institute for Life Science Entrepreneurship (ILSE) at Kean University has released “Profiles in Innovation,” the second in a series of white papers examining the state of innovation in New Jersey

Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s QDOT MICRO, a novel catheter that facilitates high power-short duration radiofrequency (RF) ablation, demonstrated safety and efficacy in achieving pulmonary vein isolation in patients with symptomatic drug-refractory paroxysmal atrial fibrillation (AF) in QDOT-FAST,** the first in-human multicenter study of the device

Maetrics, a leading international life sciences regulatory and compliance consultancy, has launched a new whitepaper highlighting the critical importance for Class I medical device manufacturers to comply with the EU Medical Device Regulation (MDR)

Biotage (STO: BIOT), a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of the Atlantic® ReadyDisk® product family - solid phase extraction (SPE) disks, pre-assembled into single-use holders, for extracting semi-volatile organic compounds from aqueous samples.